MedTrace Logo

Registry of Philadelphia-Negative Myeloproliferative Neoplasms

NCT02380378 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-04-02

No results posted yet for this study

Summary

This study was developed to document current diagnosis and treatment patterns, clinical outcomes, and health care resource use associated with Philadelphia-Negative Myeloproliferative Neoplasms, in the different risk classifications for each disease.

Conditions

Sponsors & Collaborators

  • Hospital Santa Marcelina

    collaborator OTHER

  • Instituto Nacional de Cancer, Brazil

    collaborator OTHER_GOV

  • Federal University of Minas Gerais

    collaborator OTHER

  • Irmandade da Santa Casa de Misericordia de Sao Paulo

    collaborator OTHER

  • Federal University of São Paulo

    collaborator OTHER

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Fabio P Santos · Instituto Israelita de Ensino e Pesquisa Albert Einstein´s (IIEP)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2022-12-31
Completion
2025-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380378 on ClinicalTrials.gov